Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $731M bought by 141 insiders at 96 companies
- $653M sold by 96 insiders outside a trading plan
- $1.1B sold by 354 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past week · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$247M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.4M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$68.1M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$66.3M
-
GMEGameStop CorporationRyan CohenCEO$27.6M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
AVRAnteris Technologies Global Corp.L1 Capital Pty Ltd10% owner$9.7M
-
BORRBorr Drilling LimitedTor Olav TroimDirector$6.2M
-
PAMPampa Energia S.A.Damian Miguel MindlinVicepresident$5.6M
Biggest sales
Past week · by insider, all their filings added up · planned sales marked
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
BEKEKE Holdings IncYongdong PengCEO$84.6M
-
CBRSCerebras Systems Inc.Dhiraj MallickCOO$80.8M
-
CRWDCrowdStrike Holdings, Inc.Michael SentonasPresident$64.2M
-
AAPLApple Inc ComTimothy D CookChair$63.8M
-
MPWRMonolithic Power Systems, Inc.Michael HsingCEO$40.3M
-
ACTEnact Holdings, Inc.Genworth Holdings, Inc.10% owner$37.1M
-
WDAYWorkday, Inc.David A Duffield10% owner$37.1M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer
-
Joseph D Sarafa Director, Brian J Roney CEO, Isolde O'Hanlon Director, Harold J Meloche CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
-
Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President
-
J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Phil E Mulacek DirectorEPEmpire Petroleum CorporationBuy$27K 11,915 shares at $2.25 +1.3% to stakeTraded Sep 30 Filed Oct 5
-
Dianne Ledingham DirectorPEGAPegasystems Inc.Planned sale$34K 1,000 shares at $34.15 2.5% of stakeTraded Oct 1 Filed Oct 5
-
Bruce C Cozadd DirectorJAZZJazz Pharmaceuticals plcPlanned sale$1.4M 6,000 shares at $230.33 1.7% of stakeTraded Oct 1 Filed Oct 5
-
Andy Fang DirectorDASHDoorDash, Inc.Planned sale$918K 5,000 shares at $183.69 100% of stakeTraded Oct 1 Filed Oct 5
-
George Raymond Zage III DirectorGRNDGrindr Inc.Planned sale$6.9M 500,000 shares at $13.87 6.6% of stakeTraded Oct 1–2 Filed Oct 5
-
Kira Scherer Wampler DirectorDOCSDoximity, Inc.Planned sale$58K 2,000 shares at $28.91 6.7% of stakeTraded Oct 1 Filed Oct 5
-
Tomas Braun DirectorGGALGrupo Financiero Galicia S.A.Sale$188K 39,562 shares at $4.75 13% of stakeTraded Mar 20–Sep 14 Filed Oct 5
-
Lori A Conkling DirectorIBKRInteractive Brokers Group, Inc.Buy$2,136 25 shares at $85.42 +1% to stakeTraded Oct 1 Filed Oct 5
-
Eric F. Cosentino DirectorIDTIDT CorporationSale$39K 500 shares at $78.55 93% of stakeTraded Oct 1 Filed Oct 5
-
Charles Kissner DirectorRMBSRambus, Inc.Planned sale$555K 5,000 shares at $111.00 57% of stakeTraded Oct 2 Filed Oct 5
-
Katherine W Shattuck DirectorCZNCCitizens & Northern CorpBuy$204 8 shares at $25.51 +0.1% to stakeTraded Oct 2 Filed Oct 5
-
Frank G Pellegrino DirectorCZNCCitizens & Northern CorpBuy$6,250 245 shares at $25.51 +0.5% to stakeTraded Oct 2 Filed Oct 5
-
Gavin Hattersley DirectorMKCMcCormick & Company, IncorporatedBuy$45K 1,000 shares at $44.61 +34% to stakeTraded Oct 2 Filed Oct 5
-
Aristeidis P Pittas DirectorESEAEuroseas Ltd.Buy$75K 1,050 shares at $71.07 +1.8% to stakeTraded Oct 2 Filed Oct 5
-
Chris Riccardi DirectorWVVIWillamette Valley Vineyards, Inc.Buy$4,718 2,617 shares at $1.80 +0.5% to stakeTraded Sep 25–Oct 1 Filed Oct 2
-
Michael L Speiser DirectorSNOWSnowflake Inc.Planned sale$17.5M 50,741 shares at $344.00Traded Oct 2 Filed Oct 2
-
Mary Agnes Wilderotter DirectorDOCUDocuSign, Inc.Planned sale$69K 1,000 shares at $68.80 31% of stakeTraded Oct 1 Filed Oct 2
-
Joseph F Hanna DirectorMGRCMcGrath RentCorpPlanned sale$863K 7,500 shares at $115.04 4.9% of stakeTraded Oct 1 Filed Oct 2
-
Foundation Fighting Blindness Retinal Degeneration Fund Director · +1 joint filerIRDOpus Genetics, Inc.Sale$2.8M 556,000 shares at $4.96 15% of stakeTraded Sep 30 Filed Oct 2
-
Randolph Altschuler DirectorXMTRXometry, Inc.Planned sale$1M 10,000 shares at $104.04 1.8% of stakeTraded Oct 1 Filed Oct 2
-
Richard N. Frommer DirectorPROPPrairie Operating Co.Buy$13K 28,000 shares at $0.4500 +9.2% to stakeTraded Sep 3 Filed Oct 2
-
Francis S Soistman Jr. DirectorEHTHeHealth, Inc.Planned sale$28K 40,612 shares at $0.6900 4% of stakeTraded Oct 1–2 Filed Oct 2
-
David E Housel DirectorAUBNAuburn National Bancorporation, Inc.Buy$1,402 51 shares at $27.49 +0.5% to stakeTraded Sep 30 Filed Oct 2
-
J Tutt Barrett DirectorAUBNAuburn National Bancorporation, Inc.Buy$2,007 73 shares at $27.50 +0.8% to stakeTraded Sep 30 Filed Oct 2
-
William F Ham Jr. DirectorAUBNAuburn National Bancorporation, Inc.Buy$1,288 47 shares at $27.41 +0.9% to stakeTraded Sep 30 Filed Oct 2
-
Ita M Brennan DirectorPLPlanet Labs PBCPlanned sale$187K 11,500 shares at $16.30 4.4% of stakeTraded Oct 1 Filed Oct 2
-
Frances Arnold DirectorGOOGLAlphabet Inc., Class APlanned sale$28K 83 shares at $340.45 0.4% of stakeTraded Sep 30 Filed Oct 2
-
Gregory Baszucki DirectorRBLXRoblox CorporationPlanned sale$714K 16,666 shares at $42.87 1.3% of stakeTraded Oct 1 Filed Oct 2
-
Richard A. Heyman DirectorORICOric Pharmaceuticals, Inc.Planned sale$87K 6,700 shares at $12.91Traded Oct 1 Filed Oct 2
-
John Wendell Thompson DirectorRBRKRubrik, Inc.Planned sale$1.6M 13,500 shares at $115.69Traded Oct 1 Filed Oct 2
-
Hollings Renton DirectorANABAnaptysBio, Inc.Planned sale$249K 5,000 shares at $49.87 31% of stakeTraded Oct 1 Filed Oct 2
-
Fernando Matt Borges Martins DirectorCINTCI&T IncBuy$13K 4,123 shares at $3.18 New stakeTraded Oct 1 Filed Oct 2
-
Glenn Steele Jr. MD PHD DirectorPTCTPTC Therapeutics, Inc.Planned sale$782K 12,000 shares at $65.16 35% of stakeTraded Sep 30 Filed Oct 2
-
Jeffrey Jacob Raider DirectorWRBYWarby Parker Inc.Planned sale$416K 15,000 shares at $27.70 3.4% of stakeTraded Oct 1 Filed Oct 2
-
Joseph Stilwell Director · +5 joint filersWHLRWheeler Real Estate Investment Trust, Inc.Sale$15 5 shares at $3.03 <0.1% of stakeTraded Sep 30 Filed Oct 2
-
Matthew L. Posard DirectorHALOHalozyme Therapeutics, Inc.Planned sale$568K 5,230 shares at $108.54 8.9% of stakeTraded Oct 1 Filed Oct 2
-
Daniel Freifeld DirectorMRTMarti Technologies, Inc.Sale$2.6M 1,350,000 shares at $1.91 18% of stakeTraded May 18–Sep 9 Filed Oct 2
-
Michael F Angelo DirectorVHCVirnetX Holding CorpPlanned sale$10K 1,000 shares at $10.26 3.4% of stakeTraded Sep 30 Filed Oct 2
-
Paul Cahill Sciarra DirectorJOBYJoby Aviation, Inc.Planned sale$381K 62,500 shares at $6.09 0.1% of stakeTraded Oct 2 Filed Oct 2
-
Ulrike Helfer DirectorGSLGlobal Ship Lease, Inc.Sale$179K 4,000 shares at $44.82 32% of stakeTraded Sep 30 Filed Oct 2
-
Jennifer Tejada ChairPDPagerDuty, Inc.Planned sale$1.6M 107,000 shares at $15.11 6.4% of stakeTraded Sep 30 Filed Oct 2
-
Edgar R. Smith III DirectorFGBIFirst Guaranty Bancshares, Inc.Buy$822K 99,277 shares at $8.28 +12% to stakeTraded Sep 30 Filed Oct 2
-
Watkin Phoebe L. Yang DirectorDOCSDoximity, Inc.Planned sale$34K 1,290 shares at $26.71 5% of stakeTraded Sep 30 Filed Oct 2
-
Sherri Goodman DirectorLTBRLightbridge CorporationPlanned sale$7,020 1,116 shares at $6.29 1.6% of stakeTraded Oct 1 Filed Oct 2
-
Thomas E Chorman DirectorSXIStandex International CorporationPlanned sale$14K 50 shares at $271.39 0.4% of stakeTraded Oct 1 Filed Oct 2
-
William S. Creekmuir DirectorFLXSFlexsteel Industries, Inc.Sale$101K 1,250 shares at $81.13 6.2% of stakeTraded Sep 14–15 Filed Oct 2
-
Martin Tuchman DirectorBPRNPrinceton Bancorp, Inc.Sale$95K 3,000 shares at $31.72 0.5% of stakeTraded Apr 3, 2023 Filed Oct 2
-
Theodore W Mowery DirectorMPBMid Penn BancorpBuy$1,982 56 shares at $35.40 +0.1% to stakeTraded Sep 30 Filed Oct 2
-
Joel L. Frank DirectorMPBMid Penn BancorpBuy$2,478 70 shares at $35.40 +0.6% to stakeTraded Sep 30 Filed Oct 2
-
Albert J. Evans DirectorMPBMid Penn BancorpBuy$9,983 282 shares at $35.40 +0.7% to stakeTraded Sep 30 Filed Oct 2
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.